The global market for mHealth is expected to reach $49.1 billion by 2020, according to a recent study by Grand View Research. Monitoring services are expected to remain the dominant and fastest-growing market segment, with market revenue of $1.2 billion in 2012, and an estimated CAGR of 49.7% from 2014 to 2020.
Clinicians are more open to utilizing burgeoning healthcare technology as part of their practice, and patients are more receptive to interacting with that technology, according to a new PricewaterhouseCoopers Health Research Institute report released last month titled “Healthcare delivery of the future: How digital technology can bridge the gap of time and distance between clinicians and consumers.”
Pepsi has entered the artisanal beverage space with Caleb’s Kola, a drink made with cane sugar, kola nut extract and a blend of spices packaged in 10-oz. glass bottles. Each bottle has 110 calories and 29 grams of sugar.
It’s a new era for carbonated beverages. Sales have been falling for a decade as consumers have shifted away from traditional sodas sweetened with high-fructose corn syrup and are avoiding diet sodas due to concerns about artificial sweeteners.
Last year, Drug Store Newscovered extensively the results from Thrifty White's successful medication synchronization program. DSN recently checked in with Tim Weippert, Thrifty White EVP pharmacy, to get an update.
Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.